Intercept Pharmaceuticals Inc. (ICPT)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Adorini Officer	$67.41	1,634	$110,147.94	6,392	2014-01-07	Filing
Tallarigo Large Shareholder, Director	$67.41	1,839	$123,966.99	1,640	2014-01-07	Filing
Akkaraju Director	$55.53	260	$14,436.50	2,368	2013-12-18	Filing
Shapiro Officer	$62.11	5,016	$311,550.28	3,000	2013-12-16	Filing
Adorini Officer	$51.26	380	$19,477.01	5,743	2013-11-20	Filing
Adorini Officer	$50.50	1,620	$81,808.06	6,123	2013-11-20	Filing
Shapiro Officer	$48.08	4,730	$227,412.25	4,266	2013-11-15	Filing
Veitinger Director	$49.01	100	$4,901.00	2,120	2013-11-11	Filing
Veitinger Director	$48.81	62	$3,026.22	2,220	2013-11-11	Filing
Orbimed Director	$62.50	40,088	$2,505,500.00	1,735,259	2013-10-21	Filing
Genextra Large Shareholder	$62.50	124,912	$7,807,000.00	5,938,890	2013-10-21	Filing
Micheli Large Shareholder	$62.50	124,912	$7,807,000.00	5,938,890	2013-10-21	Filing
Adorini Officer	$55.51	2,000	$111,026.60	5,743	2013-10-21	Filing
Tallarigo Large Shareholder, Director	$62.50	124,912	$7,807,000.00	5,938,890	2013-10-21	Filing
Silverstein Director	$62.50	40,088	$2,505,500.00	1,734,934	2013-10-21	Filing
Tallarigo Large Shareholder, Director	$62.50	1,123,415	$70,213,437.50	6,063,802	2013-10-15	Filing
Silverstein Director	$62.50	376,585	$23,536,562.50	1,775,022	2013-10-15	Filing
Genextra Large Shareholder	$62.50	1,123,415	$70,213,437.50	6,063,802	2013-10-15	Filing
Micheli Large Shareholder	$62.50	1,123,415	$70,213,437.50	6,063,802	2013-10-15	Filing
Orbimed Large Shareholder, Director	$62.50	376,585	$23,536,562.50	1,775,347	2013-10-15	Filing